IL32 and Miyoshi myopathy: Treatment with carfilzomib and bortezomib, proteasomal inhibitors that are used in the treatment of MM, had a similar effect: accumulation of IL-32 protein (Supplementary Figure S1C) with no change in mRNA expression (Supplementary Figure 1D).